Aflibercept
Approved for Colorectal Cancer in Europe
Aflibercept
(Zaltrap, Regeneron/Sanofi) has been approved in Europe
for use in the treatment of metastatic colorectal cancer.
By Zosia Chustecka. In Medscape
Compound
Stimulates Tumor-Fighting Protein in Cancer Therapy
A compound
that stimulates the production of a tumor-fighting protein may improve the
usefulness of the protein in cancer therapy, according to a team of
researchers, including several from the Penn State Hershey Cancer Institute and
College of Medicine
In Science Daily
Molecular
Link Between Metabolism and Breast Cancer
A protein
associated with conditions of metabolic imbalance, such as diabetes and
obesity, may play a role in the development of aggressive forms of breast
cancer, according to new findings by researchers at the National Cancer
Institute (NCI), part of the National Institutes of Health, and their
colleagues. Metabolic imbalance is often caused by elevated carbohydrate
intake, which can lead to over-activating a molecule called C-terminal binding
protein (CtBP). This over-activation, in turn, can increase the risk of breast
cancer. Results of their work appeared in Nature Communications, Feb. 5, 2013.
In Science Daily
Tiny capsule
effectively kills cancer cells
Scientists
create nanoscale vehicle to battle cancer without harming healthy cells.
By Bill Kisliuk. In UC Los
Angeles
Cancer
in the Developing World: An Under-Prioritized Threat to Health and Development
The rise of
hundreds of millions of people out of poverty during the past 50 years is a
story of tremendous, unprecedented human progress. A significant factor in this
success has been the global community's coordinated effort to tackle serious
health and economic barriers, like HIV, malaria, pneumonia, and lack of access
to family planning.
By Karl Hofmann. In Huffington Post
Matching
Tumors With The Optimal Cancer Drugs
In a new
paper, researchers assess the complete
landscape of a cancer's kinome expression and determine which kinases are
acting up in a particular tumor. Since
the proteins are relatively easy to target with drugs and plenty of kinase
inhibitors already exist, the work shows that those particular kinases can be
targeted with drugs and can even lead to potentially combining multiple drugs
to target multiple kinases
In Science 2.0
Lower
Risk of ER-Negative Breast Cancer Linked to Vegetable Consumption
Consuming
more vegetables is associated with a lower risk of estrogen receptor
(ER)-negative breast cancer, according to a new study published in the Journal
of the National Cancer Institute. Researchers from Harvard Medical
School
By Anna Azvolinsky. In Cancer Network
RNA promotes
metastasis in lung cancer
The vast
majority – approximately 80 percent – of our DNA does not code for proteins,
yet it gets transcribed into RNA. These RNA molecules are called non-coding and
fulfill multiple tasks in the cell. Alongside a well-studied group of small
RNAs, there is also a class of so-called long non-coding RNAs consisting of
more than 200 nucleotides...
In EurekAlert
(press release)
Milk Thistle
Extract, Silibinin, Could Help Protect Against Skin Cancer, Studies Show
A bright
purple flower could play a role in protecting against skin cancer, according to
two new studies.
In Huffington Post
Cancer : les taux de survie s'améliorent... si peu
Une étude portant sur 427 000 cas en France, entre 1989 et
2007, montre que la survie à 5 ans s'améliore légèrement pour la plupart des
cancers.
Par Anne Jeanblanc. Dans Le Point
Lutte contre le(s) cancer(s): les
défis de la Médecine
personnalisée!
La lutte contre le cancer est une
illustration parfaite du défi contre la complexité, cher à Edgar Morin. Les
progrès de la recherche ont certes permis d'améliorer considérablement la prise
en charge des patients cancéreux mais ont aussi révélé qu'il y avait autant de
cancers différents que de personnes atteintes. Il existe de nombreux moyens
pour une cellule de devenir cancéreuse et si l'on ne connaît pas le cheminement
exact conduisant à la tumeur, le traitement risque d'être inadapté ou peu
efficace.
Par David Khayat et Frédéric Bizard.
Dans Le Huffington Post (Blog)
Peurs, préjugés et idées reçues: des
alliés du cancer à combattre!
Le 4 février est la journée mondiale
contre le cancer et le thème choisi par l'Union internationale contre le cancer
porte, cette année, sur les peurs et les préjugés liés au cancer.
Par Jacqueline Godet. Dans Le Huffington Post (Blog)
Un mécanisme qui bloque la croissance des cellules
cancéreuses
Un mécanisme qui stoppe la croissance des cellules
cancéreuses, comme si il les privait d'une protéine clé indispensable à leur
reproduction, c’est ce qu’a découvert cette équipe de recherche de l’Université
de Pittsburgh.
Dans Santé Log
Aucun commentaire:
Enregistrer un commentaire